Yahoo · Aug 10, 2026
Best Momentum Stocks to Buy for August 10th
AVT, GEO and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 10, 2026.
NYSE · NVST
Healthcare · Medical - Equipment & Services
$28.07
Down-$0.01 (-0.04%)
Updated Aug 15, 2026, 2:08 PM
SID Score
5.2/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 21 trading sessions · Daily adjusted prices
NVST closed at $28.07 after 21 trading sessions, up 4.97% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $28.00 | $28.42 | $27.925 | $28.07 | 2.53M |
| Aug 13, 2026 | $28.90 | $29.00 | $27.87 | $28.08 | 2.65M |
| Aug 12, 2026 | $28.26 | $28.90 | $28.01 | $28.71 | 2.53M |
| Aug 11, 2026 | $28.12 | $28.99 | $27.914 | $28.52 | 2.64M |
| Aug 10, 2026 | $27.76 | $28.36 | $27.60 | $28.19 | 3.07M |
| Aug 7, 2026 | $27.60 | $28.53 | $27.395 | $28.15 | 4.07M |
| Aug 6, 2026 | $28.70 | $28.70 | $27.12 | $27.38 | 6.02M |
| Aug 5, 2026 | $27.97 | $28.68 | $27.6613 | $28.63 | 7M |
| Aug 4, 2026 | $27.44 | $28.00 | $27.32 | $27.96 | 3.18M |
| Aug 3, 2026 | $27.57 | $27.97 | $27.095 | $27.37 | 3.02M |
| Jul 31, 2026 | $27.68 | $27.68 | $26.85 | $27.31 | 3.16M |
| Jul 30, 2026 | $28.00 | $28.74 | $27.6651 | $27.78 | 2.57M |
| Jul 29, 2026 | $27.99 | $28.845 | $27.66 | $28.37 | 6.05M |
| Jul 28, 2026 | $26.81 | $27.41 | $26.74 | $26.96 | 2.39M |
| Jul 27, 2026 | $26.57 | $26.80 | $26.35 | $26.64 | 2.04M |
| Jul 24, 2026 | $26.23 | $26.765 | $26.15 | $26.33 | 1.86M |
| Jul 23, 2026 | $26.24 | $26.55 | $25.76 | $26.17 | 2.74M |
| Jul 22, 2026 | $26.92 | $27.09 | $26.335 | $26.43 | 1.93M |
| Jul 21, 2026 | $26.50 | $27.025 | $26.46 | $26.93 | 1.72M |
| Jul 20, 2026 | $26.78 | $27.00 | $26.505 | $26.58 | 1.72M |
| Jul 17, 2026 | $26.71 | $27.31 | $26.61 | $26.74 | 1.79M |
The latest Smart Investors Daily articles mentioning NVST.
NVST research
Company profile and research snapshot.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 6, 2026 | Piper Sandler | Neutral | — |
| Jul 29, 2026 | Piper Sandler | Neutral | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jun 11, 2026 | Barclays | Overweight | — |
| May 7, 2026 | Evercore ISI Group | Outperform | — |
No generated briefing is available yet.
Yahoo · Aug 10, 2026
AVT, GEO and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 10, 2026.
Yahoo · Aug 10, 2026
Examine the evolution of Envista's (NVST) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Yahoo · Aug 10, 2026
VRT, NVST, and AER it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 10, 2026.
Yahoo · Aug 9, 2026
Envista Holdings Corporation recently reported Q2 2026 results showing higher sales of US$730.5 million and net income of US$53.7 million, with earnings per share from continuing operations rising to US$0.33. Alongside these results, Envista completed share repurchases totaling 12,458,894 shares for US$250 million, while also raising its full-year 2026 guidance despite expected pricing pressure in China. Now we will examine how Envista’s raised full-year guidance and earnings momentum...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning NVST.